###begin article-title 0
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
New chemically induced skin tumour susceptibility loci identified in a mouse backcross between FVB and dominant resistant PWK
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 145 150 145 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts </italic>
###xml 437 449 437 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus spretus </italic>
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
###xml 437 448 <span type="species:ncbi:10096">Mus spretus</span>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
###xml 545 550 <span type="species:ncbi:9606">human</span>
A variety of skin cancer susceptibility among mouse strains has allowed identification of genes responsible for skin cancer development. Fifteen Skts loci for skin tumour susceptibility have been mapped so far by using the two-stage skin carcinogenesis model [induced by 7.12-dimethylbenz(a)anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)]. A few responsible genes have been identified using wild-derived dominant resistant Mus spretus mice, and one has been confirmed as a low penetrance cancer susceptibility gene in a variety of human cancers.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 359 368 359 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp1 </italic>
###xml 474 483 474 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp1 </italic>
###xml 496 502 496 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts7 </italic>
###xml 545 557 545 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus spretus </italic>
###xml 820 829 820 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D11Mit339</italic>
###xml 834 842 834 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D16Mit14</italic>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 545 556 <span type="species:ncbi:10096">Mus spretus</span>
In the present study, we found that wild-derived PWK mice developed no tumour by treatment with the two-stage skin carcinogenesis protocol. This phenotype is dominant resistant when crossed with the highly susceptible strain FVB. By analyzing the F1 backcross generation between PWK and FVB, we found empirical evidence of significant linkage at the new loci Skts-fp1 on chromosome 4 and suggestive linkage on chromosomes 1, 3, 11, 12 and 14 for skin tumour susceptibility. Skts-fp1 includes the Skts7 interval, which was previously mapped by a Mus spretus and NIH backcross. We also observed suggestive linkage on chromosomes 1 and 2 in the female population only, while suggestive linkage on chromosomes 14 and 15 only was observed in the male population. A significant genetic interaction was seen between markers of D11Mit339 and D16Mit14.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
Analysis of this new cross may facilitate the identification of genes responsible for mouse skin cancer susceptibility and may reveal their biological interactions.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 154 155 154 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 366 367 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 368 369 368 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
Germ-line mutation has been reported in tumour suppressor genes and in oncogenes that are responsible for the highly penetrated familial cancer syndrome [1]. The majority of cancers, however, are sporadic and often associated with familial aggregation. Therefore, cancer susceptibility in general is explained by multiple low penetrance cancer susceptibility genes [2,3].
###end p 9
###begin p 10
###xml 418 419 418 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 420 421 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 515 516 515 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 517 518 517 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 617 618 617 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 619 621 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 811 813 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 830 842 830 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus spretus </italic>
###xml 860 872 860 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus spretus </italic>
###xml 914 927 914 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus </italic>
###xml 968 977 968 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts1~15 </italic>
###xml 990 991 990 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 992 993 992 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 994 996 994 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 999 1006 999 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Psl1~4 </italic>
###xml 1127 1129 1127 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1130 1132 1130 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1170 1176 1170 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts1 </italic>
###xml 1216 1218 1216 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1372 1374 1372 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1377 1384 1377 1384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts13 </italic>
###xml 1418 1420 1418 1420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1427 1434 1427 1434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts14 </italic>
###xml 1452 1458 1452 1458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tgfb1 </italic>
###xml 1459 1461 1459 1461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1581 1587 1581 1587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AURKA </italic>
###xml 1748 1750 1748 1750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1751 1753 1751 1753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 280 285 <span type="species:ncbi:10090">Mouse</span>
###xml 500 505 <span type="species:ncbi:10090">mouse</span>
###xml 830 841 <span type="species:ncbi:10096">Mus spretus</span>
###xml 860 871 <span type="species:ncbi:10096">Mus spretus</span>
###xml 914 926 <span type="species:ncbi:10090">Mus musculus</span>
###xml 1730 1735 <span type="species:ncbi:9606">human</span>
###xml 1800 1805 <span type="species:ncbi:10090">mouse</span>
###xml 1909 1914 <span type="species:ncbi:9606">human</span>
Although analysis of the human population is useful in finding the gene related to high penetrance disease, the identification of low penetrance tumour susceptible genes is still difficult. This is mainly due to heterogeneous genetic background and complex environmental effects. Mouse models of cancer have been used extensively for the analysis and identification of the genetic components of tumour susceptibility [4,5]. The susceptibility for the two-stage skin carcinogenesis model varies among mouse strains [6,7], and the genetic approach has been performed to identify genes related to cancer susceptibility [8-11]. Previous studies indicate that the percent contribution of skin cancer susceptibility can be explained by each genetic component consisting of one of multiple loci and their interaction [12]. Using NIH and Mus spretus crosses, in which Mus spretus is dominant resistant against susceptible Mus musculus strains, skin cancer susceptibility loci Skts1~15 were mapped [8,9,12]. Psl1~4 were mapped by using C57BL/6J(B6) and DBA crosses, in which DBA shows semi-dominant susceptibility against resistant B6 [10,13]. Tomaso Dragani's group also mapped Skts1 using Car-R and Car-S outbred. crosses [14], which were generated by balanced intercross of inbred strains, and reported loss of tyrosinase activity conferred increased skin tumor susceptibility [15]. Skts13 was identified as the Aurka gene [16], and Skts14 was identified as Tgfb1 [11]. However, none of the responsible genes have been cloned yet at the remaining loci. Since functional polymorphisms of AURKA were repeatedly reported to be determinants of individual risk for colon, esophageal, skin, lung, breast, ovarian, and prostate cancers in the human population [16-19], identification of genetic components in the mouse skin cancer susceptibility could facilitate the identification of candidate cancer risk factors in the human population.
###end p 10
###begin p 11
###xml 282 304 282 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus musculus </italic>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 523 525 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 661 669 661 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">spretus </italic>
###xml 103 108 <span type="species:ncbi:10090">mouse</span>
###xml 258 263 <span type="species:ncbi:10090">mouse</span>
###xml 282 303 <span type="species:ncbi:39442">Mus musculus musculus</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
To narrow down the candidate loci and to identify the corresponding gene for the genetic components of mouse skin cancer susceptibility, information from other strains and crosses are valuable. In this study, we found that the PWK strain, which is an inbred mouse derived from wild Mus musculus musculus mice [20], is dominantly resistant to chemically induced skin carcinogenesis when crossed with a highly susceptible FVB strain. Because of the dominant resistance and high genetic diversity between PWK and FVB strains [21], we expected that there were multiple genetic components involved in skin cancer susceptibility as seen in our previous report of NIH/spretus cross. Therefore, we performed genetic analysis of a large backcross between PWK and FVB strains.
###end p 11
###begin title 12
Results
###end title 12
###begin p 13
###xml 256 257 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 484 485 480 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
###xml 386 390 <span type="species:ncbi:10090">mice</span>
Using the two stage skin tumour induction treatment, all 16 FVB mice developed papillomas with an average multiplicity of 32.56 +/- 3.6, at 20 weeks after the initiation. However, none of the 10 PWK/Rbrc mice developed any papillomas on dorsal skin (Table 1). Also, none of the 17 (PWK/Rbrc x FVB/N)F1 mice, abbreviated as PF, developed tumours. Four out of the 25 (FVB/N x PWK/Rbrc)F1 mice, abbreviated as FP, developed tumours, but the average multiplicity was 0.32 +/- 0.16 (Table 1). These results demonstrate that the PWK strain has a dominant resistant phenotype to the DMBA/TPA induced skin tumour against a susceptible FVB strain.
###end p 13
###begin p 14
Incidence and multiplicity of papilloma in the parental strains, F1 and F1 backcross
###end p 14
###begin p 15
###xml 0 3 0 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a) </sup>
a) data are shown as mean +/- SEM.
###end p 15
###begin p 16
###xml 340 341 338 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 348 349 346 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 615 616 613 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 564 568 <span type="species:ncbi:10090">mice</span>
Linkage analysis was performed by genotyping 208 F1 backcross mice (abbreviated as FPxF) for 204 polymorphic markers spread throughout the genome. The number of papillomas 20 weeks after the initial treatment was used as a trait. One hundred twenty three mice (56.7%) developed papillomas, and average multiplicity was 4.86 +/- 0.56 (Table 1, Fig. 1). Males developed a significantly higher number of papillomas than females. Even though it was not significantly associated, FVB males also showed higher multiplicity than FVB females. On the contrary, only female mice developed papillomas in the F1 hybrids (Table 1).
###end p 16
###begin p 17
Distribution patterns of papilloma multiplicity. The number of papillomas 20 weeks after the initiation is plotted as histograms.
###end p 17
###begin p 18
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 411 412 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 621 630 621 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D4Mit111 </italic>
###xml 634 643 634 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D4Mit308 </italic>
###xml 644 652 644 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp1</italic>
###xml 763 771 763 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D4Mit26 </italic>
###xml 775 784 775 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D4Mit146 </italic>
###xml 837 838 837 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
For parametric quantitative trait loci (QTL) regression analysis, tumour multiplicity data are transformed by root-square transformation to improve the fit of a negative binomial distribution pattern of nominal data sets to a normal distribution [22]. By single point marker regression analysis, significant linkage with likelihood ratio statistics (LRS) larger than 12.9 was mapped only on chromosome 4 (Table 2). LRS of at least 6.9 was considered evidence for suggestive linkage and was detected on chromosomes 1, 3, 4, 11, 12 and 14. Interval mapping on chromosome 4 showed highly significant linkage between markers D4Mit111 and D4Mit308 (Skts-fp1). This QTL interval covered almost one third of chromosome 4 and there seem to be at least two peaks close to D4Mit26 and D4Mit146 with values of LRS 38.5 and 40.5, respectively (Fig. 2). It was estimated that approximately 18% of the total trait variance would be explained by a QTL at this locus.
###end p 18
###begin p 19
QTL for papilloma multiplicity
###end p 19
###begin p 20
###xml 0 3 0 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a) </sup>
a) cM from the centrosome
###end p 20
###begin p 21
###xml 0 3 0 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b) </sup>
b) P-value for the association at each locus
###end p 21
###begin p 22
###xml 0 3 0 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c) </sup>
c) Data are shown as mean +/- SEM.
###end p 22
###begin p 23
Values in parenthesis are number of samples.
###end p 23
###begin p 24
* Suggestive linkage
###end p 24
###begin p 25
** Significant linkage
###end p 25
###begin p 26
*** Highly Significant linkage
###end p 26
###begin p 27
###xml 198 202 <span type="species:ncbi:10090">mice</span>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 257 261 <span type="species:ncbi:10090">mice</span>
Interval mapping on chromosome 4. The QTL on chromosome 4 shows significant linkage to multiplicity of papilloma 20 weeks after the initiation. Black line indicates the linkage calculated for whole mice, right gray is for female mice, dark gray is for male mice. Genetic distances of each marker from centrosome are indicated as genetic position (cM) on the bottom.
###end p 27
###begin p 28
###xml 361 365 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A~D</xref>
The suggestive linkage on chromosomes 1, 2, 14 and 15 showed gender difference. Linkage on chromosomes 1 and 2 was observed only in female, and linkage on chromosomes 14 and 15 was in males exclusively. Suggestive evidence of linkage at loci on chromosome 1, 2, 14 and 15 was obtained with interval mapping in either male or female population exclusively (Fig. 3A~D).
###end p 28
###begin p 29
###xml 214 218 <span type="species:ncbi:10090">mice</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
Interval mapping on chromosome 1, 2, 14 and 15. Result of interval mapping on (A) chromosome 1, (B) chromosome 2, (C) chromosome 14 and (D) chromosome 15 are shown. Right gray line indicates the linkage for female mice and dark gray line for male mice. Genetic distances of each marker from centrosome are indicated as the genetic position (cM) on the bottom.
###end p 29
###begin p 30
###xml 288 298 288 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D11Mit339 </italic>
###xml 302 310 302 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D16Mit14</italic>
###xml 375 385 375 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D11Mit339 </italic>
###xml 389 398 389 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D16Mit14 </italic>
###xml 415 416 415 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 452 461 452 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D16Mit14 </italic>
###xml 543 553 543 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D11Mit339 </italic>
###xml 629 637 629 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D16Mit14</italic>
###xml 651 661 651 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D11Mit339 </italic>
###xml 773 782 773 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp2 </italic>
###xml 809 819 809 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D11Mit155 </italic>
###xml 823 833 823 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D11Mit178 </italic>
###xml 858 866 858 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D16Mit14</italic>
###xml 915 924 915 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D16Mit14 </italic>
###xml 930 932 930 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 976 985 976 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp3 </italic>
###xml 1027 1037 1027 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D16Mit202 </italic>
###xml 1041 1051 1041 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D16Mit195 </italic>
###xml 1079 1089 1079 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D11Mit339 </italic>
###xml 1095 1097 1095 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 1155 1164 1155 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D11Mit339</italic>
###xml 1304 1313 1304 1313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D11Mit339</italic>
###xml 1346 1355 1346 1355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D11Mit339</italic>
###xml 1425 1434 1425 1434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp2 </italic>
###xml 1462 1471 1462 1471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D16Mit14 </italic>
###xml 1490 1499 1490 1499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp3 </italic>
###xml 1527 1536 1527 1536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D11Mit339</italic>
###xml 1575 1584 1575 1584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp2 </italic>
###xml 1588 1596 1588 1596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp3</italic>
###xml 591 595 <span type="species:ncbi:10090">mice</span>
###xml 842 846 <span type="species:ncbi:10090">mice</span>
###xml 899 903 <span type="species:ncbi:10090">mice</span>
###xml 1054 1058 <span type="species:ncbi:10090">mice</span>
###xml 1139 1143 <span type="species:ncbi:10090">mice</span>
###xml 1437 1441 <span type="species:ncbi:10090">mice</span>
###xml 1502 1506 <span type="species:ncbi:10090">mice</span>
To find interaction components among QTLs, a two-dimensional scan of per-mutation test using J/qtl was performed. With a standard criteria (Joint LOD>5 and [Epistatic LOD > 3 or minimum LOD {locus1, locus2} >3]), possible interactive QTL with epistatic LOD 4.14 was found between markers D11Mit339 and D16Mit14. A plot of the average number of papillomas of each genotype at D11Mit339 and D16Mit14 is shown in Fig. 4. Homozygous FVB allele (FF) at the D16Mit14 marker is associated with susceptibility if the genotype at the interacting locus D11Mit339 is a homozygous (FF) genotype. In the mice with heterozygous FP genotype at D16Mit14, genotype at D11Mit339 had no association with the multiplicity of papillomas. Interval mapping indicated a highly significant linkage Skts-fp2 (LRS 27.6) between markers D11Mit155 and D11Mit178 locus in mice with FF at D16Mit14, but no linkage was observed in mice with FP at D16Mit14 (Fig. 5A). By interval mapping, significant linkage Skts-fp3 (LRS15.3) was also mapped between markers D16Mit202 and D16Mit195 in mice with FF genotype at D11Mit339 (Fig. 5B). Some weak linkage was observed also in mice with FP at D11Mit339, however the additive effect was opposite, i.e. PWK allele on chromosome16 could be susceptible allele for skin tumor development in FP at D11Mit339, while it is resistant in FF at D11Mit339. Approximately 26% of the total trait variance would be explained by Skts-fp2 in mice with FF genotype at D16Mit14 locus, and 14% for Skts-fp3 in mice with FF genotype at D11Mit339. No sexual difference was observed in Skts-fp2 and Skts-fp3.
###end p 30
###begin p 31
###xml 28 38 28 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D11Mit339 </italic>
###xml 42 50 42 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D16Mit14</italic>
###xml 72 82 72 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D11Mit339 </italic>
###xml 217 226 217 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D16Mit14 </italic>
###xml 289 298 289 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D16Mit14 </italic>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
Allelic interaction between D11Mit339 and D16Mit14. Association between D11Mit339 genotype and multiplicity of papilloma 20 weeks after the initiation is shown. Black square indicates the mice with FF genotype at the D16Mit14 locus. White square indicates the mice with FP genotype at the D16Mit14 locus. Data are shown as mean +/- SEM.
###end p 31
###begin p 32
###xml 193 202 193 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D16Mit14 </italic>
###xml 336 345 336 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D16Mit14 </italic>
###xml 510 520 510 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D11Mit339 </italic>
###xml 654 664 654 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D11Mit339 </italic>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 257 261 <span type="species:ncbi:10090">mice</span>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
###xml 463 467 <span type="species:ncbi:10090">mice</span>
###xml 575 579 <span type="species:ncbi:10090">mice</span>
###xml 625 629 <span type="species:ncbi:10090">mice</span>
Interval mapping on chromosome 11. (A) Interval mapping results on chromosome 11 are shown for the mice with FF genotype (dark gray line) and the mice with FP genotype (right gray line) at the D16Mit14 locus. Black line indicates interval mapping for whole mice. Significant linkage is observed only in the mice with FF genotype at the D16Mit14 locus. (B) Interval mapping results on chromosome 16 are shown for the mice with FF genotype (dark gray line) and the mice with FP genotype (right gray line) at the D11Mit339 locus. Black line indicates interval mapping for whole mice. Significant linkage is observed only in the mice with FF genotype at the D11Mit339 locus. Genetic distances of each marker from centrosome are indicated as the genetic position (cM) on the bottom.
###end p 32
###begin title 33
Discussion
###end title 33
###begin p 34
###xml 374 383 374 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp1 </italic>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
The present study indicates that PWK is a dominant resistant strain to two-stage skin carcinogenesis, when crossed with highly susceptible FVB mice. Among the 20 mice in each group, no PWK developed papillomas, and only a few FP F1 hybrid mice developed one papilloma. In a 208 backcross mice study, which should detect QTLs with more than 4% variance, a significant QTL of Skts-fp1 has been mapped. The linkage study using genetically and phenotypically diverged strains FVB and PWK can facilitate analysis and understanding the genetic component of this complex cancer susceptibility.
###end p 34
###begin p 35
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 103 115 103 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus spretus </italic>
###xml 329 338 329 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp1 </italic>
###xml 388 397 388 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D4Mit111 </italic>
###xml 401 409 401 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D4Mit308</italic>
###xml 555 563 555 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp1</italic>
###xml 586 594 586 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D4Mit26 </italic>
###xml 608 617 608 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D4Mit146 </italic>
###xml 896 908 896 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus spretus </italic>
###xml 1147 1155 1147 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D4Mit26 </italic>
###xml 1159 1168 1159 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D4Mit167 </italic>
###xml 1169 1177 1169 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp1</italic>
###xml 103 114 <span type="species:ncbi:10096">Mus spretus</span>
###xml 695 699 <span type="species:ncbi:10090">mice</span>
###xml 896 907 <span type="species:ncbi:10096">Mus spretus</span>
###xml 1222 1226 <span type="species:ncbi:10090">mice</span>
PWK is a wild-derived strain that could help ensure high genetic diversity [21,23]. As seen in NIH and Mus spretus inter-specific crosses, we expected to have a large genetic variation to skin tumour susceptibility between FVB and PWK. However, we mapped a significant locus on chromosome 4 only. Interval mapping indicated that Skts-fp1 showed multiple significant peaks located between D4Mit111 and D4Mit308, which covered almost one third of chromosome 4, suggesting that a linkage group consisting of multiple genes in a chromosome may be involved in Skts-fp1. Contributions of the D4Mit26 locus and the D4Mit146 locus (two major linkage peaks between which recombination are observed in 16 mice) are estimated to explain the approximately 15% and 18% of the variance of PWK resistant phenotype, respectively. These contributions are higher than the contribution of major QTLs in the NIH and Mus spretus backcross study, indicating that contributions on a single chromosome are important in the FVB and PWK cross. Linkage analysis also showed suggestive linkage at loci on chromosomes 1, 3, 11, 12 and 14 in addition to significant linkage at D4Mit26 and D4Mit167 (Skts-fp1). Although additional markers and backcross mice are needed to hypothesize the multiple genetic effects in this cross, it is possible that many other weak loci and epistatic components contribute to the resistant phenotype of PWK.
###end p 35
###begin p 36
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts7</italic>
###xml 134 146 134 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus spretus </italic>
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 155 156 155 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 177 185 177 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp1</italic>
###xml 308 319 308 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus spretus</italic>
###xml 439 450 439 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus spretus</italic>
###xml 677 688 677 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus spretus</italic>
###xml 134 145 <span type="species:ncbi:10096">Mus spretus</span>
###xml 308 319 <span type="species:ncbi:10096">Mus spretus</span>
###xml 439 450 <span type="species:ncbi:10096">Mus spretus</span>
###xml 677 688 <span type="species:ncbi:10096">Mus spretus</span>
Skts7, which was mapped as a QTL on chromosome 4 for chemically induced skin tumour susceptibility by the analysis of the NIH/Ola and Mus spretus cross [8,9], is located within Skts-fp1. A common gene may be responsible for the skin susceptibilities of the two crosses, segregating FVB with PWK and NIH with Mus spretus. So far, the SNP information in the Phenome database is not sufficient to find common haplotype blocks between PWK and Mus spretus. However, after narrowing down the locus and carrying out expression and functional analysis of the candidate genes, we can perform a haplotype analysis identifying a common polymorphism in the gene between resistant strains (Mus spretus, PWK) and susceptible strains (NIH, and FVB). The haplotype analysis will help to identify a candidate skin resistant gene.
###end p 36
###begin p 37
###xml 202 209 202 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D4Mit31</italic>
###xml 213 221 213 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D4Mit52 </italic>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
From the study with Ornithine decarboxylase (Odc) transgenic BALB/cJ and C57BL/6J mice, significant linkage of the skin tumour induced by DMBA and the Odc transgene was detected in the interval between D4Mit31and D4Mit52 (51.3-54.9 cM) [24]. These two strains may also share a common resistant allele and could be used for haplotype mapping to identify the candidate.
###end p 37
###begin p 38
###xml 20 28 20 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp1</italic>
###xml 103 104 103 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 105 106 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 109 115 109 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pctr1 </italic>
###xml 119 125 119 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pctr2 </italic>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 215 222 215 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn2a </italic>
###xml 272 277 272 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pctr1</italic>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 286 293 286 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn2a </italic>
###xml 324 329 324 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Papg1</italic>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 394 401 394 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn2a </italic>
###xml 442 448 442 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink">INK4a </sup>
###xml 455 458 455 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ARF</sup>
###xml 555 560 555 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink">INK4a</sup>
###xml 620 626 620 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pctr1 </italic>
###xml 630 636 630 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Papg1 </italic>
###xml 669 670 669 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 699 708 699 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp1 </italic>
###xml 778 780 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 960 964 <span type="species:ncbi:10090">mice</span>
On this interval of Skts-fp1, many QTLs for susceptibility to other types of tumours have been mapped [4,5]. Pctr1 and Pctr2 have been mapped as loci for susceptibility to pristine induced plasmacytoma [25,26], and Cdkn2a has been suggested to be a corresponding gene for Pctr1[27,28]. Cdkn2a is also a strong candidate for Papg1, QTL for progression of urethane induced lung tumours [29]. The Cdkn2a locus encodes two tumour suppressors, P16INK4a and P19ARF. There are no non-synonymous polymorphisms between FVB and PWK in ankirin 1 and 2 domains of P16INK4a, which are suggested to be corresponding polymorphisms for Pctr1 and Papg1 (data not shown). Because Figure 2 shows multiple peaks at the Skts-fp1 locus on chromosome 4, as seen with other tumour susceptibility QTLs [30], the locus is complex and may create a linkage group containing two or more overlapping susceptibility and/or resistant regions. Thus, we have initiated the creation of congenic mice containing segments of the donor PWK allele on chromosome 4 to the recipient FVB background.
###end p 38
###begin p 39
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp2 </italic>
###xml 102 110 102 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D16Mit14</italic>
###xml 156 165 156 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp3 </italic>
###xml 235 245 235 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D11Mit339 </italic>
###xml 326 335 326 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp2 </italic>
###xml 339 348 339 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp3 </italic>
###xml 497 498 497 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 516 522 516 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tgfb1 </italic>
###xml 596 602 596 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts14</italic>
###xml 650 656 650 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts15</italic>
###xml 682 689 682 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tgfbm3 </italic>
###xml 705 711 705 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tgfb1 </italic>
###xml 727 729 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 732 741 732 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp2 </italic>
###xml 779 787 779 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp3</italic>
###xml 789 794 789 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Scc15</italic>
###xml 875 877 875 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 883 888 883 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sluc4</italic>
###xml 953 955 953 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 985 994 985 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp2 </italic>
###xml 1160 1169 1160 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp3 </italic>
###xml 1184 1190 1184 1190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts9 </italic>
###xml 1224 1225 1224 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1231 1238 1231 1238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sluc27 </italic>
###xml 1285 1287 1285 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1510 1512 1510 1512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1726 1735 1726 1735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp2 </italic>
###xml 1739 1748 1739 1748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp3 </italic>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 223 227 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 869 873 <span type="species:ncbi:10090">mice</span>
###xml 947 951 <span type="species:ncbi:10090">mice</span>
###xml 1570 1574 <span type="species:ncbi:10090">mice</span>
Skts-fp2 on chromosome 11 was identified as a significant linkage among FVB homozygous mice at marker D16Mit14, but not in mice heterozygous at this locus. Skts-fp3 on chromosome 16 was also identified among FVB homozygous mice at the D11Mit339 locus, but not in mice with heterozygous at this locus. Our results suggest that Skts-fp2 and Skts-fp3 showed the evidence of interaction. An interaction component between two loci has been suggested to play an important role in cancer susceptibility [4,12] and recently Tgfb1 was indicated as a corresponding gene for a skin tumour susceptible locus Skts14. This locus was shown to have interaction with Skts15, which overlaps with the Tgfbm3 locus mapped as Tgfb1 modifier locus [11]. Skts-fp2 could also be functionally related to Skts-fp3. Scc15, the QTL for 1,2-dimethylhydrazine induced colon tumour susceptibility in mice [31] and Sluc4, the QTL for N-ethyl-N-nitrosourea induced lung tumour in mice [32] have been mapped around the Skts-fp2 locus, but no QTL for skin tumor susceptibility is mapped at this locus. No QTL for susceptibility to skin cancer or other types of tumour has been mapped around the Skts-fp3 locus, however Skts9 for DMBA/TPA induced skin cancer [9] and Sluc27 for N-ethyl-N-nitrosourea induced lung tumour [33] are mapped on the same chromosome. If extreme phenotypic differences exist between two strains and dominant interactions are expected, the interaction components can be detected more efficiently using a simple backcross [12]. Although further analysis with an additional number of mice is needed to identify responsible genes at the interactedlocus and significant interaction component between two QTLs, the genetic interaction between Skts-fp2 and Skts-fp3 reveals a biological interaction of genes at two loci.
###end p 39
###begin p 40
###xml 410 414 <span type="species:ncbi:10090">mice</span>
In this study, we found that linkages at four loci show sexual difference. Suggestive linkage on chromosomes 1 and 2 was exclusively observed in females and suggestive linkage on chromosomes 14 and 15 was observed only in males. Usually this kind of study is performed with either all female or all male animals, and sexual differences in tumour susceptibility genes are not identified. An increased number of mice will enable us to reveal the QTL for tumour susceptibility, which interacts with sex chromosomes directly or indirectly.
###end p 40
###begin p 41
The absence of PWK alleles at both markers remarkably increased the average number of papillomas, whereas no effect was seen in animals that retained one PWK allele at either locus. A dominant resistant to cancer development may be redundant regulation. Candidate accessory regulatory genes modify a major effect gene and can be identified as a dominant interacted modifier. Although individual modifying genes may show only subtle quantitative effects on tumourigenesis, combinations of suppressive alleles can completely eliminate neoplasia. The identification of effective combinations of gene activities reflects the general finding of "genetic redundancy", in which the loss of function of a single gene has no obvious phenotype.
###end p 41
###begin p 42
###xml 332 337 332 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Psl2 </italic>
###xml 357 363 357 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts13</italic>
###xml 365 370 365 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Psl3 </italic>
###xml 390 395 390 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts8</italic>
###xml 481 487 481 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts1 </italic>
###xml 500 509 500 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp1 </italic>
###xml 562 568 562 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts7 </italic>
###xml 668 678 668 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
###xml 844 846 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 847 849 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 602 617 <span type="species:ncbi:10090">transgenic mice</span>
Here we present three significant loci related to skin tumour susceptibility from the analysis of a new strain combination of FVB and PWK. Among previous studies using other tumour induction systems, many tumour susceptible loci mapped on the same chromosomal regions where skin cancer susceptibility loci were mapped. For example, Psl2 was mapped close to Skts13, Psl3 was mapped close to Skts8, and the locus found from the analysis of Car-S and Car-R strains was located on the Skts1 locus. Also, Skts-fp1 identified in this study covered the region on which Skts7 and the linkage obtained from ODC transgenic mice have been mapped. As described in the studies for in silico mapping methods using many inbred strains, congenic, recombinant inbred, advanced intercross, chromosome substitution strains or very recently collaborative crosses [34-36], it is obvious that accumulated information from several genetic analyses using many other strains provides an important and rapid route to identification of complex germ-line genetic variants that confer increased cancer risk.
###end p 42
###begin title 43
Conclusion
###end title 43
###begin p 44
###xml 211 230 211 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp1, Skts-fp2 </italic>
###xml 234 242 234 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Skts-fp3</italic>
This study shows that PWK is a dominant resistant strain to two-stage skin carcinogenesis when it is crossed with the FVB strain. By linkage analysis using backcross between FVB and PWK, three significant QTLs, Skts-fp1, Skts-fp2 and Skts-fp3, for the skin tumour susceptibility locus were mapped. Studies using this new cross could be an efficient method for finding new genes responsible for skin cancer susceptibility and for examining genetic/biological interaction between the responsible genes.
###end p 44
###begin title 45
Methods
###end title 45
###begin title 46
Animals
###end title 46
###begin p 47
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 448 452 <span type="species:ncbi:10090">mice</span>
###xml 457 461 <span type="species:ncbi:10090">mice</span>
Mice used in this study were bred in the SPF Facility in the Department of Laboratory Animals at Roswell Park Cancer Institute and are treated in accordance with IACUC regulations. FVB/N mice were purchased from TACONIC (Germantown, NY). PWK/Rbrc inbred mice were obtained from RIKEN BRC (Ibaraki, Japan). Twenty five (FVB/N x PWK/Rbrc) F1 and 17 (PWK/Rbrc x FVB/N) F1, abbreviated as FP and PF respectively, were generated from the two strains of mice. FP mice were then backcrossed with FVB/N to generate 208 F1 backcross animals.
###end p 47
###begin title 48
Skin cancer induction
###end title 48
###begin p 49
7.12-Dimethylbenz(a)anthracene (DMBA) and 12-O-tetradecanoylphorbol-13-acetate (TPA) were purchased from Sigma Chemical Co. (St. Louis, MO). DMBA is used as a carcinogen and TPA as a promoter.
###end p 49
###begin p 50
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 190 194 <span type="species:ncbi:10090">mice</span>
Nine of FVB female and 7 of male mice, each 10 female and 10 male of PWK mice, 14 female and 11 male of FP hybrids, 8 female and 9 male of PF mice, 107 female and 101 male of FPxF backcross mice were applied for skin carcinogen.
###end p 50
###begin p 51
###xml 366 369 366 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5 </sup>
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
###xml 88 95 <span type="species:ncbi:191423">clipper</span>
###xml 207 212 <span type="species:ncbi:10090">mouse</span>
###xml 294 299 <span type="species:ncbi:10090">mouse</span>
###xml 331 335 <span type="species:ncbi:10090">mice</span>
At 8-11 weeks of age, the back skin of each mouse was carefully shaved with an electric clipper. Two days after shaving, 200 ul of DMBA (0.125 mg/ml) was dissolved in acetone and applied to the back of each mouse prior to the hair growth cycle. A total of 97.4 nmol of DMBA was applied to each mouse. One week after the treatment, mice received 400 ul of TPA (5 x 10-5 M solution in acetone) as a promoter, i.e., 32.4 nmol of TPA, twice weekly for 20 weeks. Animals are assessed twice weekly for the appearance of papillomas during the promotion phase. The number of papillomas was counted every other week until 20 weeks after tumour initiation. Papilloma incidence during the promotion phase and papilloma multiplicity 20 weeks after the initiation was used for assessment of skin tumour susceptibility in this study.
###end p 51
###begin title 52
Genotype
###end title 52
###begin p 53
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
Genomic DNA was isolated from mouse tails using the alkali method. Briefly, 1~2 mm of tails were boiled in 300 ul of 50 mM NaOH for 30 min, then 25 ul of 1 M Tris-HCL (ph8.0) was added. DNAs were then genotyped for 204 polymorphic microsatellite markers spaced at approximately 8-cM intervals through chromosome 1 to 19 and X by polymerase chain reaction (PCR). Information of MIT markers used in this study is available upon request. PCR reactions were carried out using a Biometlar thermocyler, and PCR products were separated by electrophoresis through 4% Nusieve-GTG low melting temperature agarose gels (FMC) in the 0.5 x TBE buffer.
###end p 53
###begin title 54
Statistical analysis
###end title 54
###begin p 55
###xml 24 26 24 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 27 29 27 29 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 890 892 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 893 895 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
MapManager QTX ver1.03 [37,38] was used to analyse phenotype and genotype data to map QTLs related to susceptibility for chemically induced skin tumours. Permutation tests were performed for FPxF F1 backcross generation, to estimate empirical threshold values for quantitative trait mapping. Single-point marker regression was performed for the whole chromosomes to find linkage, and then interval mapping was performed to analyse the chromosome with significant linkage in the single point marker regression. A permutation test (10,000 permutations at a 1 cM interval) was performed, and the significance threshold was calculated to establish the empirical significance levels in QTL mapping experiments. Suggestive (LRS > 6.9), significant (LRS > 12.9), highly significant (LRS > 20.8) thresholds were established and used for present analysis. A two-dimensional genome scan using J/qtl [39,40] was performed to analyse interactions between QTLs.
###end p 55
###begin title 56
Abbreviations
###end title 56
###begin p 57
###xml 129 133 <span type="species:ncbi:10090">mice</span>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
DMBA: 7.12-dimethylbenz(a)anthracene, TPA: 12-O-tetradecanoylphorbol-13-acetate, F: FVB/N, P: PWK/Rbrc, FP: (FVB/N x PWK/Rbrc)F1 mice, PF: (PWK/Rbrc x FVB/N)F1 mice, FPxF: (FVB/N x PWK/Rbrc) x FVB/N F1 backcross mice, LRS: likelihood ratio statistics, B6: C57BL/6J, Odc: Ornithine decarboxylase, PCR: polymerase chain reaction
###end p 57
###begin title 58
Authors' contributions
###end title 58
###begin p 59
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
JI and KF carried out skin carcinogen experiments. KF analysed the data of skin tumour developed in mice. KF and NI performed genotyping of F1 backcross mice and linkage analysis. HN (corresponding author) is the PI of the program that funded the work and designed this study. This manuscript was written by KF and HN. All authors read and approved the final manuscript.
###end p 59
###begin title 60
Acknowledgements
###end title 60
###begin p 61
This research was supported by the National Institute of Environmental Health Services to HN (ES012249-01), the Roswell Park Alliance Foundation and, in part, by the NCI Cancer Center Support Grant to Roswell Park Cancer Institute (CA016156). We are grateful to Ms. T. Triplet, Ms. D. Tabaczynski and Ms. J. Jackson for technical support; Ms. K. DeRosa, Ms. Y. Harigaya and Mr. E. Morien for genotyping analyses; and Ms. D. Ovak, Ms. E. Sanders-Noonan and Ms. J. Augus for editorial and secretarial assistance.
###end p 61
###begin article-title 62
Identification and management of inherited cancer susceptibility
###end article-title 62
###begin article-title 63
The genetics and genomics of cancer
###end article-title 63
###begin article-title 64
The search for low-penetrance cancer susceptibility alleles
###end article-title 64
###begin article-title 65
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
###xml 75 80 <span type="species:ncbi:9606">human</span>
Cancer susceptibility in the mouse: genetics, biology and implications for human cancer
###end article-title 65
###begin article-title 66
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
Genomic approaches to identification of tumour-susceptibility genes using mouse models
###end article-title 66
###begin article-title 67
###xml 111 115 <span type="species:ncbi:10090">mice</span>
Genetics of chemical carcinogenesis. 1. Bidirectional selective breeding of susceptible and resistant lines of mice to two-stage skin carcinogenesis
###end article-title 67
###begin article-title 68
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
Two-stage skin carcinogenesis in sensitive and resistant mouse strains
###end article-title 68
###begin article-title 69
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Distinct genetic loci control development of benign and malignant skin tumours in mice
###end article-title 69
###begin article-title 70
###xml 79 83 <span type="species:ncbi:10090">mice</span>
A subset of skin tumor modifier loci determines survival time of tumor-bearing mice
###end article-title 70
###begin article-title 71
###xml 147 151 <span type="species:ncbi:10090">mice</span>
Identification of novel genetic loci contributing to 12-O-tetradecanoylphorbol-13-acetate skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice
###end article-title 71
###begin article-title 72
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
Genetic variants of Tgfb1 act as context-dependent modifiers of mouse skin tumor susceptibility
###end article-title 72
###begin article-title 73
###xml 102 106 <span type="species:ncbi:10090">mice</span>
Epistatic interactions between skin tumor modifier loci in interspecific (spretus/musculus) backcross mice
###end article-title 73
###begin article-title 74
###xml 17 23 <span type="species:ncbi:10090">murine</span>
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
Association of a murine chromosome 9 locus (Psl1) with susceptibility to mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate
###end article-title 74
###begin article-title 75
###xml 26 30 <span type="species:ncbi:10090">mice</span>
Use of intercross outbred mice and single nucleotide polymorphisms to map skin cancer modifier loci
###end article-title 75
###begin article-title 76
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Loss of tyrosinase activity confers increased skin tumor susceptibility in mice
###end article-title 76
###begin article-title 77
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
###xml 98 103 <span type="species:ncbi:9606">human</span>
Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human
###end article-title 77
###begin article-title 78
Two functional coding single nucleotide polymorphisms in STK15 (Aurora-A) coordinately increase esophageal cancer risk
###end article-title 78
###begin article-title 79
STK15 polymorphisms and association with risk of invasive ovarian cancer
###end article-title 79
###begin article-title 80
Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types
###end article-title 80
###begin article-title 81
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
###xml 46 56 <span type="species:ncbi:10090">m.musculus</span>
PWD/Ph and PWK/Ph inbred mouse strains of Mus m.musculus subspecies--a valuable resouce of phenotypic variations and genomic polymorphisms.
###end article-title 81
###begin article-title 82
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
A comprehensive SNP-based genetic analysis of inbred mouse strains
###end article-title 82
###begin article-title 83
Statistical methods for the analysis of tumor multiplicity data.
###end article-title 83
###begin article-title 84
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
An efficient SNP system for mouse genome scanning and elucidating strain relationships
###end article-title 84
###begin article-title 85
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
Identification of an X-linked locus modifying mouse skin tumor susceptibility
###end article-title 85
###begin article-title 86
###xml 99 103 <span type="species:ncbi:10090">mice</span>
Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice.
###end article-title 86
###begin article-title 87
The plasmacytoma resistance gene, Pctr2, delays the onset of tumorigenesis and resides in the telomeric region of chromosome 4.
###end article-title 87
###begin article-title 88
Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1
###end article-title 88
###begin article-title 89
p16 INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB
###end article-title 89
###begin article-title 90
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
A strong candidate gene for the Papg1 locus on mouse chromosome 4 affecting lung tumor progression
###end article-title 90
###begin article-title 91
The Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64
###end article-title 91
###begin article-title 92
###xml 9 14 <span type="species:ncbi:10090">mouse</span>
Five new mouse susceptibility to colon cancer loci, Scc11-Scc15.
###end article-title 92
###begin article-title 93
###xml 141 146 <span type="species:ncbi:10090">mouse</span>
Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse.
###end article-title 93
###begin article-title 94
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
Complexity of lung cancer modifiers: mapping of thirty genes and twenty-five interactions in half of the mouse genome
###end article-title 94
###begin article-title 95
###xml 55 59 <span type="species:ncbi:10090">mice</span>
In silico mapping of complex disease-related traits in mice.
###end article-title 95
###begin article-title 96
###xml 6 11 <span type="species:ncbi:10090">mouse</span>
Using mouse models to dissect the genetics of obesity
###end article-title 96
###begin article-title 97
The collavorative cross, a community resouce for the genetic analysis of complex traits.
###end article-title 97
###begin article-title 98
Map Manager QTX, cross-platform software for genetic mapping.
###end article-title 98
###begin article-title 99
A statistical framework for quantitative trait mapping
###end article-title 99

